U.S. Apollo, Blackstone, Hershey
Aug 13 (Reuters) -Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies including Apollo, Blackstone and Hershey, on Tuesday.
HIGHLIGHTS
* Apollo APO.N: Jefferies cuts target price to $114 from $129 |
* Blackstone BX.N: Jefferies raises target price to $147 from $138 |
* Hershey Co HSY.N: Goldman Sachs initiates coverage with sell rating |
* Palomar Holdings Inc PLMR.O: KBW raises target price to $113 from $96 |
* Walmart WMT.N: CFRA raises target price by $3 to $75 |
Following is a summary of research actions on U.S. companies reported by Reuters on Tuesday. Stock entries are in alphabetical order.
* 10X Genomics Inc TXG.O: Morgan Stanley cuts target price to $46.00 from $50.00 |
* 10X Genomics Inc TXG.O: UBS cuts target price to $25 from $30 |
* Academy Sports and Outdoors Inc ASO.O: TD Cowen cuts target price to $54 from $58 |
* Academy Sports and Outdoors Inc ASO.O: TD Cowen cuts to hold from buy |
* Academy Sports and Outdoors Inc ASO.O: Wells Fargo cuts target price to $46 from $55 |
* Adverum Biotechnologies Inc ADVM.O: RBC cuts target price to $12 from $15 |
* AIG AIG.N: Jefferies cuts target price to $82 from $84 |
* AIG AIG.N: TD Cowen cuts target price to $80 from $83 |
* Airsculpt Technologies Inc AIRS.O: Leerink Partners cuts PT to $3.75 from $5 |
* Akamai Technologies Inc AKAM.O: D.A. Davidson raises target price to $120 from $115 |
* Akoya Biosciences Inc AKYA.O: Piper Sandler cuts target price to $4 from $6 |
* Alarm.com Holdings Inc ALRM.O: JP Morgan cuts target price to $65 from $70 |
* Alta Equipment Group Inc ALTG.N: D.A. Davidson cuts target price to $12 from $20 |
* AMC Networks Inc AMCX.O: TD Cowen cuts target price to $11 from $16 |
* American Public Education Inc APEI.O: Truist Securities cuts target to $15 from $20 |
* Amprius Technologies Inc AMPX.N: Northland Capital cuts target price to $4 from $10 |
* Antero Resources Corp AR.N: BMO cuts target price to $33 from $36 |
* Apellis Pharmaceuticals Inc APLS.O: JP Morgan cuts target price to $64 from $72 |
* Apollo APO.N: Jefferies cuts target price to $114 from $129 |
* Aramark ARMK.N: Citigroup raises target price to $40.50 from $36.50 |
* Ardent Health Partners Inc ARDT.N: Stephens initiates coverage with overweight rating |
* Ardent Health Partners Inc ARDT.N: Stephens initiates coverage with price target $24 |
* Ares Management Corp ARES.N: Jefferies cuts target price to $137 from $139 |
* ARS Pharmaceuticals Inc SPRY.O: Raymond James raises target price to $22 from $18 |
* ARS Pharmaceuticals Inc SPRY.O: Raymond James raises to strong buy from outperform |
* Arthur J. Gallagher & Co. AJG.N: TD Cowen raises target price to $288 from $273 |
* Artiva Biotherapeutics Inc ARTV.O: Needham initiates with buy rating; PT $23 |
* Artiva Biotherapeutics Inc ARTV.O: TD Cowen initiates coverage with buy rating |
* Artiva Biotherapeutics Inc ARTV.O: Wedbush initiates with outperform rating; PT $18 |
* Arvinas Inc ARVN.O: Citigroup cuts target price to $30 from $38 |
* Assurant Inc AIZ.N: UBS raises target price to $217 from $210 |
* Astria Therapeutics ATXS.O: Oppenheimer raises target price to $26 from $25 |
* Atea Pharmaceuticals Inc AVIR.O: Morgan Stanley raises PT to $6.88 from $2.00 |
* Atea Pharmaceuticals Inc AVIR.O: Morgan Stanley raises to equal-weight from underweight |
* Azek Company Inc AZEK.N: JP Morgan cuts target price to $48 from $52 |
* Baker Hughes Co BKR.O: BMO raises target price to $43 from $40 |
* Baldwin Insurance Group Inc BWIN.O: UBS raises target price to $49 from $43 |
* Belite Bio, Inc BLTE.O: H.C. Wainwright raises target price to $60 from $59 |
* Biohaven Ltd BHVN.N: UBS cuts target price to $54 from $55 |
* Bioventus Inc BVS.O: Canaccord Genuity raises target price to $12 from $8 |
* Blackstone BX.N: Jefferies raises target price to $147 from $138 |
* Boundless Bio Inc BOLD.O: Guggenheim cuts target price to $20 from $24 |
* Boundless Bio Inc BOLD.O: Leerink Partners cuts target price to $21 from $25 |
* Broadwind Inc BWEN.O: Craig-Hallum cuts target price to $4 from $5 |
* Bsr Real Estate Investment Trust HOMu.TO: BMO raises PT to $14.50 from $13.50 |
* Cambium Networks Corp CMBM.O: Jefferies cuts target price to $1.75 from $4 |
* Cannae Holdings Inc CNNE.N: Stephens cuts target price to $28 from $31 |
* Carlyle Group Inc CG.O: Jefferies cuts target price to $44 from $45 |
* Centerpoint Energy CNP.N: Wells Fargo cuts to equal weight from overweight |
* Centerpoint Energy, Inc. CNP.N: Wells Fargo cuts target price to $28 from $32 |
* Charles River Laboratories International CRL.N: Mizuho cuts target to $210 from $235 |
* Chevron Corp CVX.N: BMO cuts target price to $160 from $175 |
* Chord Energy Corp CHRD.O: BMO cuts target price to $205 from $220 |
* Civitas Resources Inc CIVI.N: BMO cuts target price to $75 from $82 |
* Clearway Energy Inc CWEN.N: RBC raises target price to $30 from $26 |
* Cogent Communications Holdings CCOI.O: BofA Global Research raises PT to $75 from $70 |
* Coherent Corp COHR.N: Stifel raises target price to $75 from $68 |
* CommScope Holding Company Inc COMM.O: Jefferies raises PT to $2.50 from $1 |
* Compass Therapeutics Inc CMPX.O: Leerink Partners cuts target price to $5 from $10 |
* Conagra Brands Inc CAG.N: Goldman Sachs initiates coverage with buy rating |
* Conagra Brands Inc CAG.N: Goldman Sachs initiates coverage with target price $36 |
* Conocophillips COP.N: BMO cuts target price to $123 from $130 |
* Constellation Energy Corp CEG.O: RBC cuts target price to $214 from $218 |
* Construction Partners Inc ROAD.O: D.A. Davidson raises target price to $55 from $50 |
* Coterra Energy Inc CTRA.N: BMO cuts target price to $32 from $33 |
* Crown Castle Inc CCI.N: BofA Global Research raises price objective to $115 from $110 |
* CVR Energy Inc CVI.N: UBS cuts target price to $30 from $33.75 |
* CVS Health Corp CVS.N: Mizuho cuts target price to $66 from $72 |
* Cytek Biosciences Inc CTKB.O: Piper Sandler cuts target price to $8 from $8.5 |
* Danimer Scientific Inc DNMR.N: TD Cowen cuts target price to $1 from $2 |
* Danimer Scientific Inc DNMR.N: TD Cowen cuts to hold from buy |
* Deere & Co DE.N: JP Morgan cuts target price to $360 from $375 |
* Dell Technologies Inc DELL.N: Barclays raises to equal weight from underweight |
* Devon Energy Corp DVN.N: BMO cuts target price to $52 from $55 |
* Diamondback Energy Inc FANG.O: UBS cuts target price to $245 from $257 |
* Dick's Sporting Goods, Inc. DKS.N: Wells Fargo cuts target price to $227 from $230 |
* Digital Realty Trust Inc DLR.N: Truist Securities raises PT to $168 from $160 |
* Draftkings Inc DKNG.O: Morgan Stanley cuts target price to $47.00 from $51.00 |
* Duke Energy Corp DUK.N: RBC raises target price to $119 from $113 |
* Dyne Therapeutics Inc DYN.O: Chardan Capital Markets raises PT to $50 from $42 |
* Dyne Therapeutics Inc DYN.O: H.C. Wainwright raises target price to $55 from $48 |
* Dyne Therapeutics Inc DYN.O: Jefferies raises target price to $50 from $42 |
* Dyne Therapeutics Inc DYN.O: Piper Sandler raises target price to $53 from $43 |
* Echostar Corp SATS.O: UBS raises target price to $15 from $14 |
* Envestnet Inc ENV.N: Jefferies raises target price to $63.15 from $59 |
* EOG Resources Inc EOG.N: BMO raises target price to $140 from $137 |
* EQT Corp EQT.N: BMO cuts target price to $39 from $45 |
* Equinix EQIX.O: Deutsche Bank raises target price to $910 from $880 |
* Esperion Therapeutics Inc ESPR.O: Needham cuts target price to $6 from $8 |
* Exxon Mobil XOM.N: BMO raises target price to $127 from $125 |
* Eyepoint Pharmaceuticals Inc EYPT.O: JP Morgan cuts target price to $29 from $32 |
* Fortrea Holdings Inc FTRE.O: Citigroup cuts target price to $30 from $42 |
* Fortrea Holdings Inc FTRE.O: Evercore ISI cuts target price to $22 from $27 |
* Fortrea Holdings Inc FTRE.O: Jefferies cuts target price to $25 from $32 |
* Fortrea Holdings Inc FTRE.O: Mizuho cuts target price to $22 from $27 |
* Fortrea Holdings Inc FTRE.O: TD Cowen cuts target price to $23 from $27 |
* General Mills GIS.N: Goldman Sachs initiates coverage with buy rating |
* General Mills GIS.N: Goldman Sachs initiates coverage with target price $76 |
* Genprex Inc GNPX.O: Alliance Global Partners cuts target price to $7.50 from $8 |
* Getty Images Holdings Inc GETY.N: Citigroup cuts target price to $5 from $6 |
* Getty Images Holdings Inc GETY.N: Macquarie cuts target price to $3.5 from $4 |
* Gitlab Inc GTLB.O: Mizuho cuts target price to $58 from $62 |
* Glacier Bancorp Inc GBCI.N: Piper Sandler cuts target price to $38 from $39 |
* Guardant Health Inc GH.O: Piper Sandler raises target price to $34 from $30 |
* Halliburton Co HAL.N: BMO cuts target price to $40 from $44 |
* Hamilton Lane Inc HLNE.O: Morgan Stanley raises target price to $140 from $132 |
* Hanover Insurance Group Inc THG.N: KBW raises target price to $144 from $142 |
* Hershey Co HSY.N: Goldman Sachs initiates coverage with sell rating |
* Hershey Co HSY.N: Goldman Sachs initiates coverage with target price $185 |
* Hess HES.N: BMO cuts target price to $155 from $170 |
* HF Sinclair Corp DINO.N: BMO cuts target price to $57 from $60 |
* HF Sinclair Corp DINO.N: UBS cuts target price to $70 from $73 |
* Hilton Worldwide Holdings Inc HLT.N: CFRA cuts target price to $236 from $242 |
* Hilton Worldwide Holdings Inc HLT.N: Morgan Stanley cuts PT to $233 from $237 |
* Horace Mann Educators Corp HMN.N: KBW cuts target price to $39 from $40 |
* Hormel Foods Corp HRL.N: Citigroup raises target price to $37 from $33 |
* Hormel Foods Corp HRL.N: Citigroup raises to buy from neutral |
* Humacyte Inc HUMA.O: BTIG cuts target price to $10 from $11 |
* Idacorp Inc IDA.N: Mizuho raises target price to $102 from $99 |
* Illumina Inc ILMN.O: Piper Sandler cuts target price to $195 from $200 |
* Immunome Inc IMNM.O: Piper Sandler cuts target price to $23 from $27 |
* Immunovant Inc IMVT.O: UBS cuts target price to $41 from $42 |
* Inozyme pharma Inc INZY.O: Jefferies assumes coverage with buy rating |
* Inozyme pharma Inc INZY.O: Jefferies assumes coverage with target price $17 vs $16 |
* Jeld-Wen Holding Inc JELD.N: Jefferies cuts target price to $15 from $16 |
* Kellanova K.N: Goldman Sachs initiates coverage with neutral rating; PT $75 |
* Kemper Corp KMPR.N: UBS raises target price to $71 from $67 |
* Keycorp KEY.N: CFRA raises target price by $5 to $17 |
* Keycorp KEY.N: CFRA raises to hold from sell |
* Keycorp KEY.N: Citigroup raises target price to $19 from $18 |
* Keycorp KEY.N: Wedbush raises target price to $17 from $16 |
* Kilroy Realty Corp KRC.N: Jefferies cuts target price to $42 from $45 |
* KKR KKR.N: Jefferies raises target price to $130 from $126 |
* Kraft Heinz KHC.O: Goldman Sachs initiates coverage with sell rating |
* Kraft Heinz KHC.O: Goldman Sachs initiates coverage with target price $34 |
* Lexeo Therapeutics, Inc. LXEO.O: H.C. Wainwright cuts target price to $21 from $22 |
* Littelfuse Inc LFUS.O: Stifel raises target price to $280 from $270 |
* Littelfuse Inc LFUS.O: Stifel raises to buy from hold |
* Main Street Capital Corp. MAIN.N: Oppenheimer raises target price to $44 from $43 |
* Marathon Oil Corp MRO.N: BMO cuts target price to $29 from $30 |
* Marathon Oil Corp MRO.N: UBS cuts target price to $30 from $32 |
* Marathon Petroleum Corp MPC.N: BMO raises target price to $200 from $195 |
* Maravai Lifesciences MRVI.O: Morgan Stanley cuts target price to $10.00 from $11.00 |
* Maravai Lifesciences MRVI.O: Morgan Stanley cuts to equal-weight from overweight |
* Marriott International Inc MAR.O: UBS cuts target price to $244 from $267 |
* Matador Resources Co MTDR.N: BMO cuts target price to $75 from $79 |
* MeiraGTx Holdings Plc MGTX.O: RBC cuts target price to $9 from $11 |
* Meridianlink Inc MLNK.N: UBS raises target price to $18 from $17 |
* Mind Medicine (Mindmed) Inc MNMD.O: RBC cuts target price to $20 from $22 |
* Mondelez MDLZ.O: Goldman Sachs initiates coverage with buy rating |
* Mondelez MDLZ.O: Goldman Sachs initiates coverage with target price $80 |
* Morgan Stanley Direct Lending Fund MSDL.N: RBC cuts target price to $22 from $23 |
* Murphy Oil Corp MUR.N: BMO cuts target price to $42 from $50 |
* Murphy Oil Corp MUR.N: UBS cuts target price to $45 from $49 |
* Myriad Genetics Inc MYGN.O: Jefferies raises target price to $22 from $20 |
* Myriad Genetics Inc MYGN.O: Piper Sandler raises target price to $30 from $28 |
* Natera Inc NTRA.O: Morgan Stanley raises target price to $132.00 from $125.00 |
* Natera Inc NTRA.O: Piper Sandler raises target price to $150 from $120 |
* Neuronetics Inc STIM.O: Canaccord Genuity cuts target price to $3 from $6 |
* Neuronetics Inc STIM.O: William Blair cuts to market perform |
* Occidental Petroleum Corp OXY.N: BMO cuts target price to $70 from $75 |
* Occidental Petroleum Corp OXY.N: JP Morgan cuts target price to $71 from $73 |
* Occidental Petroleum Corp OXY.N: Stephens raises target price to $77 from $76 |
* Oric Pharmaceuticals ORIC.O: Oppenheimer cuts target price to $15 from $17 |
* Ovintiv Inc OVV.N: BMO cuts target price to $54 from $61 |
* Pacific Biosciences of California PACB.O: Stephens cuts PT to $2.50 from $3.50 |
* Pacira Biosciences Inc PCRX.O: Truist Securities cuts target price to $8 from $30 |
* Pacira Biosciences Inc PCRX.O: Truist Securities cuts to sell from buy |
* Pacs Group Inc PACS.N: Citigroup raises target price to $41 from $34 |
* Pacs Group Inc PACS.N: Oppenheimer raises target price to $40 from $32 |
* Pacs Group Inc PACS.N: Oppenheimer raises target price to $40 from $32 |
* Pacs Group Inc PACS.N: Stephens raises target price to $40 from $37 |
* Palo Alto Networks Inc PANW.O: Mizuho raises target price to $380 from $350 |
* Palo Alto Networks Inc PANW.O: UBS raises target price to $345 from $300 |
* Palomar Holdings Inc PLMR.O: KBW raises target price to $113 from $96 |
* Par Pacific Holdings Inc PARR.N: Mizuho cuts target price to $30 from $33 |
* Paycor HCM Inc PYCR.O: Truist Securities cuts target price to $20 from $33 |
* PBF Energy Inc PBF.N: BMO cuts target price to $42 from $50 |
* PBF Energy Inc PBF.N: UBS cuts target price to $44 from $57 |
* Permian Resources Corp PR.N: BMO cuts target price to $21 from $22 |
* Perspective Therapeutics CATX.A: Oppenheimer cuts target price to $17 from $19 |
* Phillips 66 PSX.N: BMO raises target price to $155 from $150 |
* Plymouth Industrial REIT Inc PLYM.N: Truist Securities raises target to $26 from $24 |
* Prudential Financial Inc PRU.N: UBS raises target price to $119 from $112 |
* Range Resources Corp RRC.N: BMO cuts target price to $33 from $38 |
* Replimune Group Inc REPL.O: JP Morgan cuts target price to $14 from $17 |
* Revance Therapeutics Inc RVNC.O: Guggenheim cuts to neutral from buy |
* Revance Therapeutics Inc RVNC.O: H.C. Wainwright cuts to neutral; raises PT to $6.6 |
* Revance Therapeutics Inc RVNC.O: Mizuho cuts target price to $6.66 from $8 |
* Revance Therapeutics Inc RVNC.O: Needham cuts to hold from buy |
* Revance Therapeutics Inc RVNC.O: Piper Sandler cuts to neutral from overweight |
* Revance Therapeutics Inc RVNC.O: Piper Sandler raises target price to $6.66 from $6 |
* Revance Therapeutics Inc RVNC.O: William Blair cuts to market perform |
* Rockwell Automation Inc ROK.N: Berenberg cuts target price to $250 from $270 |
* Root Inc ROOT.O: UBS cuts target price to $61 from $71 |
* Rubrik Inc RBRK.N: Mizuho cuts target price to $43 from $46 |
* RXO Inc RXO.N: Jefferies cuts target price to $31 from $33 |
* Ryan Specialty Holdings Inc RYAN.N: UBS raises target price to $76 from $67 |
* Savara Inc SVRA.O: Jefferies raises target price to $8.50 from $7 |
* Scpharmaceuticals Inc SCPH.O: Leerink Partners cuts target price to $20 from $22 |
* Seer Inc. SEER.O: Morgan Stanley cuts target price to $3.00 from $7.00 |
* Sharkninja Inc SN.N: BofA Global Research raises price objective to $110 from $100 |
* SM Energy Co SM.N: BMO cuts target price to $50 from $52 |
* Snowflake Inc SNOW.N: Mizuho cuts target price to $165 from $180 |
* Southwestern Energy Co SWN.N: BMO cuts target price to $7 from $8 |
* Starbucks SBUX.O: Piper Sandler raises target price to $103 from $85 |
* Starbucks SBUX.O: Piper Sandler raises to overweight from neutral |
* Starbucks SBUX.O: TD Cowen raises to buy from hold; raises target to $105 from $81 |
* Sun Communities Inc SUI.N: Truist Securities raises target price to $138 from $127 |
* Sunnova Energy International Inc NOVA.N: Guggenheim raises PT to $14 from $10 |
* Syros Pharmaceuticals Inc SYRS.O: Piper Sandler cuts target price to $5 from $13 |
* Syros Pharmaceuticals, Inc. SYRS.O: H.C. Wainwright cuts target price to $6 from $15 |
* Talos Energy Inc TALO.N: Stephens raises target price to $25 from $24 |
* Targa Resources Corp TRGP.N: RBC raises target price to $153 from $147 |
* Target Corp TGT.N: Stifel cuts target price to $147 from $170 |
* Taysha Gene Therapies Inc TSHA.O: Needham cuts target price to $6 from $7 |
* Tela Bio Inc TELA.O: Canaccord Genuity cuts target price to $12 from $14 |
* Tela Bio Inc TELA.O: Jefferies cuts target price to $14 from $18 |
* Tela Bio Inc TELA.O: Piper Sandler cuts target price to $8 from $10 |
* Telos Corp TLS.O: BMO cuts target price to $3 from $4 |
* TPG Inc TPG.O: Jefferies raises target price to $43 from $40 |
* TPG Inc TPG.O: Morgan Stanley raises target price to $55 from $52 |
* Transdigm Group Inc TDG.N: Jefferies cuts target price to $1,515 from $1,625 |
* Travere Therapeutics Inc TVTX.O: JP Morgan raises target price to $20 from $19 |
* Trubridge Inc TBRG.O: RBC raises target price to $14 from $13 |
* TTEC Holdings Inc TTEC.O: Canaccord Genuity cuts target price to $4.50 from $8 |
* TTEC Holdings Inc TTEC.O: Northland Capital cuts target price to $16 from $19 |
* Ultragenyx Pharmaceutical Inc RARE.O: Citigroup cuts target price to $111 from $118 |
* Unitil Corp UTL.N: RBC raises target price to $55 from $52 |
* Urgent.Ly Inc ULY.O: Needham cuts target price to $2 from $5 |
* US Foods Holding Corp USFD.N: CFRA cuts target price to $55 from $63 |
* US Foods Holding Corp USFD.N: CFRA cuts to hold from buy |
* US Foods Holding Corp USFD.N: JP Morgan raises target price to $60 from $58 |
* Vacasa VCSA.O: Deutsche Bank cuts target price to $2.50 from $6.50 |
* Vera Therapeutics Inc VERA.O: JP Morgan cuts target price to $62 from $65 |
* Veracyte Inc VCYT.O: Stephens raises target price to $34 from $32 |
* Veralto Corp VLTO.N: UBS initiates coverage with neutral rating and target price $118 |
* Verastem Inc VSTM.O: Truist Securities cuts target price to $15 from $18 |
* Vicarious Surgical RBOT.N: TD Cowen adjusts PT to $10 from $1.50 to reflect 1-for-30 reverse stock split |
* Victory Capital Holdings Inc VCTR.O: Morgan Stanley raises PT to $40.00 from $39.00 |
* Victory Capital Holdings Inc VCTR.O: RBC cuts target price to $55 from $56 |
* Vital Energy Inc VTLE.N: BMO cuts target price to $48 from $55 |
* Walmart WMT.N: CFRA raises target price by $3 to $75 |
* Walmart WMT.N: Stifel raises target price to $73 from $71 |
* Warner Bros Discovery Inc WBD.O: Bernstein cuts target price to $8 from $10 |
* Warner Bros Discovery Inc WBD.O: Bernstein cuts to market-perform from outperform |
* Warner Music Group Corp WMG.O: Deutsche Bank cuts target price to $36 from $42 |
* Westlake Corp WLK.N: BMO raises target price to $171 from $167 |
* Whitestone REIT WSR.N: Truist Securities raises target price to $15 from $14 |
* Xylem Inc XYL.N: UBS initiates coverage with buy rating and target price $165 |
* Y-Mabs Therapeutics Inc YMAB.O: BMO cuts target price to $25 from $26 |
* Y-Mabs Therapeutics Inc. YMAB.O: Morgan Stanley cuts PT to $11.00 from $12.00 |
* Zoom Video Communications Inc ZM.O: Citigroup cuts target price to $67 from $77 |
* Zscaler Inc ZS.O: Mizuho cuts target price to $210 from $220 |
(Compiled by Bengaluru Newsroom)
</body></html>免责声明: XM Group仅提供在线交易平台的执行服务和访问权限,并允许个人查看和/或使用网站或网站所提供的内容,但无意进行任何更改或扩展,也不会更改或扩展其服务和访问权限。所有访问和使用权限,将受下列条款与条例约束:(i) 条款与条例;(ii) 风险提示;以及(iii) 完整免责声明。请注意,网站所提供的所有讯息,仅限一般资讯用途。此外,XM所有在线交易平台的内容并不构成,也不能被用于任何未经授权的金融市场交易邀约和/或邀请。金融市场交易对于您的投资资本含有重大风险。
所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。
本网站上由XM和第三方供应商所提供的所有内容,包括意见、新闻、研究、分析、价格、其他资讯和第三方网站链接,皆保持不变,并作为一般市场评论所提供,而非投资性建议。所有在线交易平台所发布的资料,仅适用于教育/资讯类用途,不包含也不应被视为适用于金融、投资税或交易相关咨询和建议,或是交易价格纪录,或是任何金融商品或非应邀途径的金融相关优惠的交易邀约或邀请。请确保您已阅读并完全理解,XM非独立投资研究提示和风险提示相关资讯,更多详情请点击 这里。